Target intelligence / Profile preview

Phospholipase A2 group XIIA pseudogene 1 (PLA2G12AP1)

Target: PLA2G12AP1
Molecular classification: Other

Overview

PLA2G12AP1 stands for phospholipase A2 group XIIA pseudogene 1, which is annotated as a *pseudogene* and not an active protein-coding gene. While the functional gene in this family, PLA2G12A (phospholipase A2 group XIIA), encodes a secreted phospholipase A2 enzyme involved in lipid metabolism and is being studied for its biological roles and disease associations, PLA2G12AP1 is not known to be expressed as a protein or to play a direct biological function. Therefore, PLA2G12AP1 is not considered a therapeutic target, and there are no recognized biological functions, disease roles, drugs, mechanisms of action, biomarkers, or safety concerns associated with it[1][3][6].

Other names: PLA2G12AP1phospholipase A2 group XIIA pseudogene 1

Beyond the preview

Go deeper on Phospholipase A2 group XIIA pseudogene 1 (PLA2G12AP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipase A2 group XIIA pseudogene 1 (PLA2G12AP1).

Explore the full profile